Siga Technologies (SIGA) is a biotechnology company engaged in the development and commercialization of pharmaceutical solutions for some of the most lethal disease-causing pathogens in the world, including smallpox, Ebola, dengue and Lassa fever. This stock is trading up 7.3% to $3.21 in recent trading.
Today’s Range: $3.00-$3.21
52-Week Range: $2.20-$3.89
Three-Month Average Volume: 176,071
From a technical perspective, SIGA is ripping higher here right above it 200-day moving average of $2.88 with above-average volume. This move has started to push shares of SIGA into breakout territory, since the stock has cleared some near-term overhead resistance levels at $3.03 to $3.17.
That would be KRAM-MA, my second best contrarian indicator in the universe!
Heed any thing he says at your financial peril.
SIGA will shoot to da moon cuz it has THE CURE, graduated from a biotech startup to a biotech producer, has a $400M +200M in options contract with a potential for the remaining $2.2B, has the ONLY CURE that meets the FED NHP requirement of curing smallpox infected monkeys unlike CMX-001 which has not been successful in curing infected monkeys.
The frosting will be if the POOP decision is reversed, reduced, or remanded with instructions.
Remember PIP had its submission rejected by the FDA due to a credibility issue.
How can anyone believe anything they say with out backup proof?